The Montreal-based oncology company now has liquidity reserves of about US$400 million, which it will put towards research and development over the next two years. (La Presse)
Skip to content
The Montreal-based oncology company now has liquidity reserves of about US$400 million, which it will put towards research and development over the next two years. (La Presse)
Talking point: It’s the second share offering in 18 months for the company, which was founded in 2016 and develops DNA repair therapies for the treatment of various cancers.The company has been in a deficit position since its founding, according to PitchBook data. Last year, the provincial government’s investment arm and the venture capital fund of the province’s largest union federation pledged a total of $150 million to support the biotech and life-sciences sectors.
Loading...
Thanks for sharing!
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseThis account has reached its share limit.
If you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseGift the full article!
You have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Most Popular This Week
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
News
Everything you need to know about the debate over stablecoin yields
Briefing
PSP posts 6.5% return, boosts Canadian assets
Canada lacks tech to protect its own classified information, top cyber official warns
RBC’s data-centre lending business has grown ‘significantly,’ CEO says
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
Exclusive events
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.
